What is Biote?
Biote is a healthcare innovation company dedicated to transforming the aging process through personalized, evidence-based approaches. Rejecting the notion of anti-aging, Biote champions healthy aging by developing advanced educational programs and patient management strategies. Their focus is on empowering healthcare providers to proactively address the early indicators of aging on an individual patient basis, fostering a new paradigm in age-related wellness and care.
How much funding has Biote raised?
Biote has raised a total of $175M across 1 funding round:
Debt
$175M
Debt (2021): $175M with participation from Truist Securities
Key Investors in Biote
Truist Securities
Truist Securities is a full-service corporate and investment banking firm with a rich history, offering comprehensive financial solutions to clients. Their involvement suggests a strong validation of Biote's business model and market potential.
What's next for Biote?
With a substantial enterprise-level funding injection, Biote is poised for significant expansion and further innovation in the healthy aging market. This major strategic investment will likely fuel advancements in their proprietary educational platforms and patient management technologies. The company is expected to scale its operations, enhance its research and development capabilities, and potentially broaden its market reach, solidifying its position as a leader in personalized age-related healthcare solutions.
See full Biote company page
